Literature DB >> 595252

Cocaine use by the otolaryngologist: a survey.

M E Johns, R L Henderson.   

Abstract

The unique characteristics of cocaine--anesthesia and vasoconstriction--make it a valuable nasal anesthetic which is a safe topical anesthetic when used properly. The safe dose limit for cocaine used topically in the nose is surely greater than 200 mg, as evidenced by 826 otolaryngologists using greater than 200 mg in their daily practice without ever having experienced a cocaine reaction. Cocaine reactions are not simply dose-dependent, as evidenced by reactions occurring with as little as 10 mg. Fatalities secondary to topical application of cocaine to the nasal mucous membranes are exceedingly rare; only 15 fatalities have been seen in the entire clinical practices of the 2,434 physicians responding in this survey. Establishing 200 mg as the safe limit for cocaine in our literature, althugh it is not based on experimental evidence, is haphazard and carries far-reaching medicolegal implication to 48% of otolaryngologists who use greater than 200 mg of cocaine. A controlled scientific study to elucidate experimental data regarding the toxicity of cocaine in clinically useful doses is urgently needed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 595252

Source DB:  PubMed          Journal:  Trans Sect Otolaryngol Am Acad Ophthalmol Otolaryngol        ISSN: 0161-696X


  4 in total

1.  Effects of intranasal cocaine on sympathetic nerve discharge in humans.

Authors:  T N Jacobsen; P A Grayburn; R W Snyder; J Hansen; B Chavoshan; C Landau; R A Lange; L D Hillis; R G Victor
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  Cocaine-induced vasoconstriction in the human coronary microcirculation: new evidence from myocardial contrast echocardiography.

Authors:  Swaminatha V Gurudevan; Michael D Nelson; Florian Rader; Xiu Tang; Joshua Lewis; Jimmy Johannes; J Todd Belcik; Robert M Elashoff; Jonathan R Lindner; Ronald G Victor
Journal:  Circulation       Date:  2013-06-28       Impact factor: 29.690

Review 3.  Clinical use of cocaine. A review of the risks and benefits.

Authors:  R M Middleton; M B Kirkpatrick
Journal:  Drug Saf       Date:  1993-09       Impact factor: 5.606

4.  Moffett's Solution Causes Significantly Greater Postoperative Throat Pain Compared to Cophenylcaine in Sinonasal Surgery.

Authors:  Dominic Ku; Kartik Vasan; Eugene Wong; Evan Tseros; Narinder Pal Singh
Journal:  Int J Otolaryngol       Date:  2019-07-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.